MedPath

APO-APREMILAST TABLETS

APO-APREMILAST TABLETS

Approved
DIN Number

02541661

Drug Class

Human

Market Date

N/A

Company
HC

Apotex Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02541661
AIG Number0356230001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L04AA32 APREMILAST
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification90:24.24.92
Health Canada Classification

ACTIVE INGREDIENTS (3)

APREMILASTActive
Strength: 10 MG
Monograph: APREMILAST
APREMILASTActive
Strength: 20 MG
Monograph: APREMILAST
APREMILASTActive
Strength: 30 MG
Monograph: APREMILAST

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.